(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

R&D AB

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

R&D AB

ST13

US500000073807819

Class

1

Filing

73807819

Registration

1619282

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

23

Latest update

01/07/2021

Trademark type

Combined

Nice classes

1

Filing date

06/19/1989

Registration date

10/30/1990

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/07/2021

Last transaction

01/07/2021

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

03/25/1985

First use in commerce

05/28/1985

Drawing code

5

Owner type

03

Owner location

Las Vegas, NV

Examiner

BLUE, RACHEL

Law office

570

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

RESEARCH & DIAGNOSTIC ANTIBODIES
RESEARCH & DIAGNOSTIC ANTIBODIES

Representatives

THEODORE J. BIELEN, JR.

Technical classification

Nice Classes

Class 1

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

MONOCLONAL ANTIBODIESPOLYCLONAL ANTISERAIMMUNOCHEMICAL REAGENTS USED FOR IMMUNOASSAYS OR HISTOCHEMICAL DETERMINATIONS OF ANTIGENS IN BIOLOGICAL SPECIMENS OR SYNTHETIC PREPARATIONS; AND IMMUNOASSAY KITS CONSISTING PRIMARILY OF SYNTHETIC PEPTIDE STANDARDASSAY BUFFERANTI-PEPTIDE ANTIBODIESLABELED TRACER FOR THE DETERMINATION OF THE CONTENT OF PEPTIDE IN BIOLOGICAL SPECIMENS OR SYNTHETIC PREPARATIONS

Publications

History of USPTO decisions and trademark events.

23 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

01/07/2021

RNL3

REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)

01/07/2021

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

01/07/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/07/2021

E89R

TEAS SECTION 8 & 9 RECEIVED

10/14/2020

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

10/30/2019

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

11/01/2010

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

11/01/2010

E89R

TEAS SECTION 8 & 9 RECEIVED

10/29/2010

CFIT

CASE FILE IN TICRS

12/29/2008

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

03/14/2001

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

03/14/2001

89AF

REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED

10/30/2000

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

09/03/1996

815F

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

06/10/1996

R.PR

REGISTERED-PRINCIPAL REGISTER

10/30/1990

PUBO

PUBLISHED FOR OPPOSITION

08/07/1990

NPUB

NOTICE OF PUBLICATION

07/11/1990

NPUB

NOTICE OF PUBLICATION

07/10/1990

NPUB

NOTICE OF PUBLICATION

07/07/1990

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/21/1990

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/09/1990

CNRT

NON-FINAL ACTION MAILED

10/11/1989

Continuous trademark protection

Get notified about every new filing that threatens R&D AB or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.